Combined Use of Rheometry and GPC/SEC for Characterising Ionic Polysaccharides
Poster Mar 18, 2015
John Duffy, Bernd Schaefer, Bert Postma
The widespread use of ionic polysaccharides like Hyaluronan, Chitosan and Carrageenan in applications as broad as medical, cosmetics and foods generates a demand for ever more detailed and accurate material characterization. Applications require ever higher material specifications, and business need ever leaner production techniques. Shorter consumer product cycles also put pressure on the development teams. This results in requests for shorter development times and more specific information about the materials used.
Rheology and Size Exclusion Chromatography (SEC/GPC) are both well established methods for the characterization of polysaccharide solutions. SEC targets characterization on a molecular scale whereas rheology offers insights into properties on a more macroscopic scale. Linking the results of independent characterization technologies results in a much more complete picture of the samples under investigation. This poster shows how Rheometry and GPC can be used as complementary tools for characterising the behaviour of polysaccharides in solution.
Identifying Non-Intentionally Added Substances (NIAS) in Food Contact MaterialsPoster
Concern about the safety of food products has increased dramatically with intentionally and non-intentionally added substances (NIAS) used in packaging being of particular interest. APGC and high resolution MS together with a workflow driven process was used to identify unknown compounds in packaging.READ MORE
Human exposure to cyanotoxins: Exploring in vitro detoxification using atmospheric cold plasma treatment to protect human healthPoster
Recently, there have been increases in freshwater harmful algal blooms. There is therefore a need to try and effectively detoxify drinking water contaminated with cyanotoxins to safeguard human health by use of new and novel techniques.READ MORE
The Role of K13 in Artemisinin ResistancePoster
Plasmodium falciparum is evolving resistance to Artemisinin Combination Therapy. The gene with the strongest association with resistance is K13. K13 is an ortholog of the well characterized transcriptional regulator Keap1. In this work we transcriptionally characterized a mutant with a transposon inserted in the K13 promoter region which results in dysregulation of K13 at 2 points of the intraerythrocytic cycle of the life-cycle to identify the processes regulated by K13.READ MORE